Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities.
Nyasha Bakare, Ivor Ralph Edwards, Andy Stergachis and 11 more
PLoS Medicine · 2011
doi:10.1371/journal.pmed.1001054 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Jur Strobos and colleagues describe the deliberations of a recent multi-stakeholder meeting discussing the creation of a sustainable global pharmacovigilance system for antiretroviral drugs that would be applicable in resource limited settings.
Abstract licence: CC0
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.